Cite
HARVARD Citation
Reyes, A. et al. (2019). Efficacy of emicizumab prophylaxis versus factor VIII prophylaxis for treatment of hemophilia A without inhibitors: network meta-analysis and sub-group analyses of the intra-patient comparison of the HAVEN 3 trial. Current medical research and opinion. pp. 2079-2087. [Online].